Skip to content

Sublingual Versus Oral Misoprostol for induction of labour at term

Sublingual Versus Oral Misoprostol for induction of labour at term

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/07/007116
Enrollment
120
Registered
2016-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Term Pregnancy

Interventions

Intervention1: 50mcg sublingual misoprostol: No. of women delivering vaginally in 24hrs Control Intervention1: 50mcg oral misoprostol: no. of women delivering vaginally in 24hrs.

Sponsors

Kasturba Medical College
Lead Sponsor
Dr Rajya Lakshmi
Collaborator
DrShraddha Shetty
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Live singleton pregnancy at a gestational age of 37 weeks or more with medical or obstetric indication for induction. Cephalic presentation Unfavourable cervix (Bishopâ??s score Reassuring fetal heart tracing

Exclusion criteria

Exclusion criteria: Cephalopelvic disproportion. Previous caesarean section or history of uterine surgery. Multiple gestations. Malpresentation. Known hypersensitivity reactions to the use of prostaglandins Known contraindications to the use of prostaglandins (eg. Asthma) Parity > 4 Significant maternal or fetal concerns requiring induction under continuous monitoring

Design outcomes

Primary

MeasureTime frame
Number of women delivering vaginally within 24 hours.Timepoint: December 2014 to November 2016

Secondary

MeasureTime frame
The time interval from induction to vaginal delivery. No. of misoprostol doses required. No. of patients requiring oxytocin augmentation No. of failed inductions. No. of Caesarean section No. of Uterine hyperstimulation Neonatal outcomes Gastrointestinal side effects and pyrexia Timepoint: December 2014 to November 2016

Countries

India

Contacts

Public ContactRekha Parimkayala

Kasturba Medical College.

shraddha_k1@rediffmail.com9886792043

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026